Recent Comments
Talkback: Response to Article in Nature, A To-Do List for the New FDA Commissioner, by Susan Okie, M.D.

Talkback: Response to A...

ARTICLE: http://content.nejm.org/cgi/content/full/360/14/1373 The article in Nature by Dr. Susan Okie titled, A To-Do List for the New FDA Commissioner, was an unfair indictment of an agency that still maintains the world’s “gold standard” and has done so for over 100 years....
The Future of Convergent Technologies

The Future of Convergen...

BIOMEDevice Forum 2009 (Report from BIOMEDevice 2009 Executive Forum) I took time off to finalize my doctoral thesis draft and research bleeding edge companies presenting at BIOMEDevice 2009 held at Boston Convention Center on Tuesday April 21st through Wednesday, April 22, 2009....
The medical device industry and the role of CDRH

The medical device indu...

A current pacemaker. Future devices are getting smaller and more complex. The public trust manufacturers of medical products to develop and commercialize devices that are safe for humans. There are many types of medical devices varying in complexity, some as simple as contact lenses...
Introduction to the Nanotechnology series…….

Introduction to the Nan...

The potential and benefits of nanotechnology are promising and unknowingly dangerous The series on nanotechnology will address many important and foundational questions posed in the entry and commercialization of novel particles employing novel technology and useful in multiple applications...